Honey Bee Genome Project – HBGP.

Honey Bee Genome Project – HBGP.

Honey Bee Genome Project: It is extremely fortunate that the Honey Bee Genome Project (HBGP) is now completed. Thanks must be given to Dr. Gene Robinson and his colleagues who developed the white paper that was the basis for DNA sequencing. Learn more about the honey bee genome project here. Potential expected results for supporting the HBGP, include the following:

Honey Bee Genome Project – HBGP

Novel antibiotics:

Increased drug resistance by pathogenic bacteria has created an urgent demand for new antibiotics. Insects are among the more promising sources of novel antibiotics and honey bees likely offer a rich source because of their sociality. Usually, honey bees live in a social environment like humans with nearly ideal conditions for the growth and transmission of pathogens.

Infectious disease:

Humans show both antigen-specific and innate immune responses to important pathogens including Mycobacterium tuberculosis and Streptococcus pneumonia. A better understanding of innate immunity can help counter these diseases, especially when vaccines have limited effectiveness.

Bee venom, anaphylaxis, and human allergic disease:

Honey bees protect their hive aggressively with both sophisticated behavioral and biochemical mechanisms. Bee venom has proved to work with a wide range of medically important and pharmacologically active compounds.


Honey bees are the foremost beneficial insect worldwide. While best known for honey, the honey bee’s more significant contribution to human nutrition is crop pollination, valued at nearly $15 billion/year in the US. Pollination increases the quantity and quality of fruits, nuts, and seeds, many of them increasingly recognized as sources of nutraceuticals. But parasites and pathogens compromise bee health and pollination activities. An HBGP will help to breed bees that resist disease and insecticides, pollinate more efficiently, but stingless.

1 of 2

error: Content is protected !!